According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2023 the company made an earning of -NZ$31.09 Million, an increase over its 2022 earnings that were of -NZ$93.62 Million. The earnings displayed on this page is the company's Pretax Income.